Abstract
Objectives
To evaluate the risk of BlCa developing after radiation for PCa, stratified by ethnicity and follow-up duration.
Methods
The 1973–2011 surveillance, epidemiology and end results database was used to determine the observed and expected number of BlCa after PCa radiation. The adjusted relative risks (RRs) of developing BlCa were calculated for the various radiation modalities relative to no radiation, stratified by ethnicity and follow-up duration. BlCa characteristics were compared between patients with a history of prostate radiation and those without PCa.
Results
PCa was radiated in 346,429 men, 6401 of whom developed BlCa versus 2464 expected cases [SIR (95 % CI) of 2.60 (2.53–2.66)]. All radiation modalities were found to have an increased RR of developing BlCa after 10 years, with brachytherapy having a significantly higher RR than external beam radiation (EBRT) or combined EBRT and brachytherapy in Caucasian men and a significantly higher RR than EBRT in men of other/unknown ethnicity. Post-radiation BlCa, in particular that after brachytherapy, had higher grade (P = 0.0001) and lower stage (P = 0.0001) versus the general population.
Conclusions
The increased risk of BlCa after prostate radiation occurs predominantly after 10 years, regardless of ethnicity. The RR of developing BlCa after 10 years is significantly higher following brachytherapy than after EBRT or EBRT and brachytherapy. Bladder cancers after prostate radiation, especially after brachytherapy, are generally lower stage but higher grade than those in patients without PCa.
Similar content being viewed by others
References
Litwin MS, Gore JL, Kwan L et al (2007) Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 109:2239
Sanda MG, Dunn RL, Michalski J et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358:1250
Liauw SL, Sylvester JE, Morris CG et al (2006) Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 66:669
Neugut AI, Ahsan H, Robinson E et al (1997) Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 79:1600
Brenner DJ, Curtis RE, Hall EJ et al (2000) Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88:398
Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2004. Bethesda, Maryland: National Cancer Institute, www.seer.cancer.gov/csr/1975_2004, based on November 2006 SEER data submission, posted to the SEER web site 2007
Rapiti E, Fioretta G, Verkooijen HM (2008) Increased risk of colon cancer after external radiation therapy for prostate cancer. Int J Cancer 123:1141
Huang J, Kestin LL, Ye H et al (2011) Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer. Radiother Oncol 98:81
Singh AK, Mashtare TL, McCloskey SA et al (2010) Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis. Int J Radiat Oncol Biol Phys 78:1086
Chrouser K, Leibovich B, Bergstralh E et al (2005) Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 174:107
Pickles T, Phillips N (2002) The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984–2000. Radiother Oncol 65:145
Murray L, Henry A, Hoskin P et al (2013) Second primary cancers after radiation for prostate cancer: a review of data from planning studies. Radiat Oncol 8:172
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973–2011), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014, based on the November 2013 submission
Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969–2012) (www.seer.cancer.gov/popdata), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released March 2014
Schoenberg BS, Myers MH (1977) Statistical methods for studying multiple primary malignant neoplasms. Cancer 40:1892
Breslow NE, Day NE (1987) Statistical methods in cancer research, vol II., The design and analysis of cohort studiesInternational Agency for Research on Cancer, Lyon, pp 69–72
Lönn S, Gilbert ES, Ron E et al (2010) Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer. Cancer Epidemiol Biomarkers 19:464
Singh A, Kinoshita Y, Rovito PM Jr (2005) Higher than expected association of clinical prostate and bladder cancers. J Urol 173:1526
Nieder AM, Porter MP, Soloway MS (2008) Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. J Urol 180:2005
Pawlish KS, Schottenfeld D, Severson R et al (1997) Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study. Prostate 33:75
Abdel-Wahab M, Reis IM, Hamilton K et al (2008) Second primary cancer after radiotherapy for prostate cancer—a SEER analysis of brachytherapy versus external beam radiotherapy. Int J Radiat Oncol Biol Phys 72:58
Boorjian S, Cowan JE, Konety BR (2007) Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 177:883
Hinnen KA, Schaapveld M, van Vulpen M et al (2011) Prostate brachytherapy and second primary cancer risk: a competitive risk analysis. J Clin Oncol 29:4510
Musunuru H, Mason M, Murray L et al (2014) Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer. Clin Oncol 26:210
Abern MR, Dude AM, Tsivian M et al (2013) The characteristics of bladder cancer after radiotherapy for prostate cancer. Urol Oncol 31:1628
Suit H, Goldberg S, Niemierko A et al (2007) Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 167:12
Shah SK, Lui PD, Baldwin DD et al (2006) Urothelial carcinoma after external beam radiation therapy for prostate cancer. J Urol 175:2063
Bostrom PJ, Soloway MS, Manoharan M et al (2008) Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy. J Urol 179:91
Yee DS, Shariat SF, Lowrance WT et al (2010) Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. J Urol 183:1751
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical standards
This work is original and not under consideration elsewhere. All guidelines listed under the author submission instructions have been followed and met. This article does not contain any studies with human participants or animals performed by any of the authors.
Author’s contribution
Keehn participated in protocol/project development and manuscript writing/editing. Ludmir and Taylor involved in data collection or management and data analysis. Rabbani performed the protocol/project development, manuscript writing/editing, data collection or management and data analysis.
Rights and permissions
About this article
Cite this article
Keehn, A., Ludmir, E., Taylor, J. et al. Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality. World J Urol 35, 713–720 (2017). https://doi.org/10.1007/s00345-016-1934-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-016-1934-z